Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-023312
Filing Date
2025-02-19
Accepted
2025-02-19 16:58:50
Documents
135
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rare-20241231.htm   iXBRL 10-K 4894600
2 EX-10.15 rare-ex10_15.htm EX-10.15 424770
3 EX-10.16 rare-ex10_16.htm EX-10.16 40139
4 EX-10.38 rare-ex10_38.htm EX-10.38 91245
5 EX-10.77 rare-ex10_77.htm EX-10.77 19588
6 EX-10.84 rare-ex10_84.htm EX-10.84 125419
7 EX-10.89 rare-ex10_89.htm EX-10.89 91307
8 EX-10.93 rare-ex10_93.htm EX-10.93 25189
9 EX-19.1 rare-ex19_1.htm EX-19.1 106333
10 EX-21.1 rare-ex21_1.htm EX-21.1 22874
11 EX-23.1 rare-ex23_1.htm EX-23.1 6776
12 EX-31.1 rare-ex31_1.htm EX-31.1 17027
13 EX-31.2 rare-ex31_2.htm EX-31.2 16470
14 EX-32.1 rare-ex32_1.htm EX-32.1 13094
15 GRAPHIC img216877578_0.jpg GRAPHIC 264788
16 GRAPHIC img216877578_1.jpg GRAPHIC 59583
  Complete submission text file 0000950170-25-023312.txt   20817803

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rare-20241231.xsd EX-101.SCH 2319263
138 EXTRACTED XBRL INSTANCE DOCUMENT rare-20241231_htm.xml XML 3961128
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

EIN.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36276 | Film No.: 25641376
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)